FindTrial
Sign In

The screening value of combined measurement of multiple serum tumor markers in cervical cancer

The screening value of combined measurement of multiple serum tumor markers in cervical cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023180
Enrollment
Unknown
Registered
2019-05-15
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical squamous cell carcinoma

Interventions

Gold Standard:Pathological examination
Index test:multiple&#32
small&#32
molecular&#32
markers

Sponsors

Nanjing Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: cervical squamous cell carcinoma patient confirmed by pathological examination.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. coagulation disorders; 3. Infection at any site; 4. Liver function was abnormal, the increase of alanine aminotransferase or glutamic oxaloacetic aminotransferase was more than three times of normal; 5. Poor control of blood pressure or blood sugar.

Design outcomes

Primary

MeasureTime frame
Receiver operating characteristic curve;—

Secondary

MeasureTime frame
Sensitivity;Specificity;Yoden index;—

Countries

China

Contacts

Public ContactLiu Guangquan

Nanjing Maternity and Child Health Hospital

w467205559@126.com+86 18994080535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026